Oaktree Acquisition Corp. III Life Sciences (OACC) Gamma Exposure (GEX) & Greeks

Gamma exposure (GEX) analysis shows how options positioning creates dealer hedging pressure across strikes. Includes delta, vanna, charm, vomma, and vega exposure by strike price.

Oaktree Acquisition Corp. III Life Sciences (OACC) operates in the Financial Services sector, specifically the Shell Companies industry, with a market capitalization near $262.5M, listed on NASDAQ, employing roughly 3 people, carrying a beta of -0.04 to the broader market. Oaktree Acquisition Corp. Led by Zaid Pardesi, public since 2024-12-16.

Greeks exposure analysis shows dealer hedging pressure across strike prices for all six Greeks. No recent options activity for OACC as of 2026-06-02; this typically reflects low options liquidity, a recently listed name, or a temporary data feed delay. Snapshot will refresh on the next active session.

Learn how gamma exposure is reported and how to read the data →